THE 9-valent human papillomavirus (HPV) vaccine - which protects people against diseases caused by nine different types of HPV - could help protect men against cancer, according international research published in JAMA Oncology.
While only offered to females in some countries, in Australia the 9vHPV vaccine (Gardasil 9) is free for all people aged nine to 25 years under the NIP.
The team looked at data from over 615,000 males vaccinated with the 9vHPV vaccine and close to 2.3 million unvaccinated males aged between nine and 26 years, and found those who were vaccinated had a lower risk of HPV-related cancers - which included head and neck, oesophageal, anal and penile cancers - than their unvaccinated peers.
"This study found a significant negative association of the 9-valent HPV vaccine with HPV-related cancers in adolescents and young adult males and contributes to the development of sex-neutral HPV vaccination," the researchers concluded. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Apr 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Apr 26
